With more than 40 years of history, since 1999, we have been pursuing an expansion strategy based on a combination of strong organic growth and acquisitions of clinical analysis and imaging services companies - all of them carefully selected and with strong brand loyalty in the market. Thanks to this strategy, Diagnósticos da América S/A (DASA) has become the largest company in the industry in Latin America.
We are the first company in the healthcare industry to trade its shares on the Brazilian capital markets. We have already begun this process based on the highest standards of corporate governance by listing our securities on the São Paulo Stock Exchange's (Bovespa) Novo Mercado .
We believe that we are well positioned to continue our growth. This belief is based on our commitment to maintain service reliability and quality, on the benefits arising from our economies of scale and on our structure of multi-brand, segmented patient service centers operating in the principal regions of Brazil and offering a wide range of diagnostic services. The Brazilian market continues to offer possibilities
for geographic expansion and consolidation in our industry with potentially favorable consequences for the consumer in terms
of enhanced service quality as well as price.
Português 
